Yale Cancer Center Researchers Identify New Role for Immune-Boosting Protein “STING” in Treatment of Head and Neck Cancer
In a study by Yale Cancer Center, researchers report on the discovery of a new role for STimulator of INterferon Genes or STING. STING has traditionally been implicated in the immune response to DNA damage, however, in this study, the focus is on STING’s role in the tumor DNA damage response.
A Pressing Need for New Ideas for Pancreatic Cancer
Despite poor outcomes nationally and internationally, patients do better when they receive treatment at facilities like Smilow Cancer Hospital. Our unique ability to bring together clinicians and scientists focused on pancreatic cancer is propelling research advances and bringing renewed hope to patients.
Rallying Resources Around DNA Repair Research
When it comes to unlocking the secrets of DNA repair, Yale Cancer Center has an armamentarium at work. In the last two years, Yale’s team has made significant advances in targeting the BRCA-dependent DNA repair axis for cancer therapy and determined that both BRCA1 and BRCA2 protein are involved in DNA repair, but they have fundamentally different mechanisms.
Comprehensive Breast Cancer Care at the Smilow Cancer Hospital Care Centers in Trumbull, Fairfield, and at Bridgeport Hospital
Smilow Cancer Hospital, in partnership with the Norma Pfriem Breast Center in Trumbull, Fairfield, and at Bridgeport Hospital, are at the forefront of providing innovative and compassionate multi- disciplinary breast care.
Winners Announced for Annual Yale Cancer Center Conclave Awards
Yale Cancer Center held its annual Conclave award ceremony virtually on January 26th to celebrate faculty and provider accomplishments 2020. Faculty and staff were honored with clinical and research prizes including the Ruth McCorkle Oncology Advanced Practice Provider Award, the Class of ‘61 Cancer Research Award, and the Yale Cancer Center Lifetime Achievement Award.
Damon Runyon Cancer Research Foundation Awards $2.65M to Innovative Early Career Scientists
The Damon Runyon Cancer Research Foundation announced that seven scientists with novel approaches to fighting cancer have been named 2021 recipients of the Damon Runyon-Rachleff Innovation Award. Five initial grants of $400,000 over two years were awarded to early career scientists whose projects have the potential to significantly impact the prevention, diagnosis and treatment of cancer. Each project will have the opportunity for up to two additional years of funding (four years total for $800,000). This year, “Stage 2” continuation support was granted to two awardees who demonstrated significant progress on their proposed research during the first two years of the award.Source: Damon Runyon News
Yale Cancer Center Research Highlighted at ASTRO 2020
Yale Cancer Center (YCC) scientists presented research at the 62nd annual American Society for Radiation Oncology (ASTRO) virtual meeting held October 25-28. The conference brings together clinicians and researchers from all oncology disciplines to exchange ideas and promote multidisciplinary care for cancer.